BIO-Europe Spring® 2017: Key considerations in microbiome partnering

March 29, 2017
The human microbiome is garnering research interest across the globe and industry is responding to the growing possibilities of therapeutic developments in a variety of ways, a key aspect of which is partnerships. The current state of play means emerging companies are often looking for specific expertise or experience in their partners, often influenced by the variety of approaches under different regulatory jurisdictions or financial structures.
Previous Article
Digital medicine takes small steps toward Big Data
Digital medicine takes small steps toward Big Data

Across a fragmented European landscape multiple programs advance the digitization of data as building block...

Next Article
BIO-Europe Spring 2017 kicks off this week in Barcelona
BIO-Europe Spring 2017 kicks off this week in Barcelona